Notably, Orai1 is a novel molecular regulator of tumorigenicity and stemness, thus targeting Orai1 signaling may be a plausible therapeutic modality against cancer and microgravity might be a new good perspective in GBM therapy (Shi et al., 2015). The gene discussed is ORAI1; the disease is glioblastoma.